Syntara's Valuation Assumes $750 Million Licensing Deal for Drug Candidate, Eruoz Hartleys Says

MT NewswiresMar 27 22:48 ET

Syntara Started at Spec Buy by Euroz Hartleys >SNT.AU

Dow JonesMar 26 18:33 ET

Syntara Develops Drug Candidate for Hypertrophic Scars, Shares Rise 3%

MT NewswiresMar 18 01:04 ET

Syntara Ltd: Half Year Report and Appendix 4D

ASXFeb 25 23:18 ET · Announcements

Syntara Target Price Raised 20% to A$0.12/Share by Bell Potter>SNT.AU

Dow JonesDec 17, 2024 19:28 ET

Syntara Ltd Secures A$15 Million for Clinical Trials

TipRanksDec 11, 2024 20:10 ET